Koichiro Furuta

495 total citations
16 papers, 188 citations indexed

About

Koichiro Furuta is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Koichiro Furuta has authored 16 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Hepatology and 2 papers in Surgery. Recurrent topics in Koichiro Furuta's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (7 papers) and Hepatitis B Virus Studies (6 papers). Koichiro Furuta is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (7 papers) and Hepatitis B Virus Studies (6 papers). Koichiro Furuta collaborates with scholars based in Japan, South Korea and Singapore. Koichiro Furuta's co-authors include Shunji Ishihara, Yuji Amano, Yoshikazu Kinoshita, Shuichi Sato, Kyoichi Adachi, Tatsuya Miyake, Masahiko Kondo, Masayuki Kurosaki, Yasunori Kadowaki and Yuko Mishima and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.

In The Last Decade

Koichiro Furuta

16 papers receiving 183 citations

Peers

Countries citing papers authored by Koichiro Furuta

Since Specialization

Citations

This map shows the geographic impact of Koichiro Furuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichiro Furuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichiro Furuta more than expected).

Fields of papers citing papers by Koichiro Furuta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koichiro Furuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichiro Furuta. The network helps show where Koichiro Furuta may publish in the future.

Co-authorship network of co-authors of Koichiro Furuta

This figure shows the co-authorship network connecting the top 25 collaborators of Koichiro Furuta. A scholar is included among the top collaborators of Koichiro Furuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichiro Furuta. Koichiro Furuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Head‐to‐Head Comparison of Long‐Term HCC Risk of Antivirals‐Treated Versus Untreated Low‐Level Viremia in HBV‐Compensated Cirrhosis 2025 ·Journal of Gastroenterology and Hepatology ·Nobuharu Tamaki, Daniel Q. Huang, (unknown), Soo Young Park, Yu Rim Lee, Dong Hyun Sinn, Tae Seop Lim, Hiroyuki Marusawa, Seng Gee Lim, (unknown), Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Masayuki Kurosaki, Beom Kyung Kim	1
2	Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis 2023 ·Hepatology ·Daniel Q. Huang, Nobuharu Tamaki, (unknown), Soo Young Park, Yu Rim Lee, Hye Won Lee, Seng Gee Lim, Tae Seop Lim, Masayuki Kurosaki, Hiroyuki Marusawa, Toshie Mashiba, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Namiki Izumi, Beom Kyung Kim, Dong Hyun Sinn	10
3	Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B 2022 ·Journal of Medical Virology ·Shun Kaneko, Masayuki Kurosaki, Toshie Mashiba, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Yasushi Uchida, Hideki Fujii, Takehiro Akahane, Hitoshi Yagisawa, Atsunori Kusakabe, Haruhiko Kobashi, Takehiko Abe, Hideo Yoshida, Chikara Ogawa, Koichiro Furuta, Nobuharu Tamaki, Keiji Tsuji, (unknown), Namiki Izumi, (unknown)	4
4	A validation study of after direct‐acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct‐acting antiviral therapy and achieved sustained virological response 2021 ·JGH Open ·Toshifumi Tada, Masayuki Kurosaki, Nobuharu Tamaki, Yutaka Yasui, Nami Mori, Keiji Tsuji, Chitomi Hasebe, (unknown), Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hiroyuki Kimura, Hitoshi Yagisawa, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Hideo Yoshida, Yasushi Uchida, Shinichiro Nakamura, Namiki Izumi	6
5	Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus 2020 ·Clinical Infectious Diseases ·Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, Nami Mori, Keiji Tsuji, Chitomi Hasebe, (unknown), Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hiroyuki Kimura, Hitoshi Yagisawa, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Hideo Yoshida, Yasushi Uchida, Rohit Loomba, Namiki Izumi	25
6	THU-150-Factors associated with treatment failure with SOF+RBV in patients with genotype 2 chronic hepatitis C and consideration of retreatment with GLE+PIB in patients not responding to SOF+RBV 2019 ·Journal of Hepatology ·Atsunori Kusakabe, Masayuki Kurosaki, Jun Itakura, Kouji Joko, Takehiro Akahane, Haruhiko Kobashi, Tetsuro Sohda, Keiji Tsuji, (unknown), Hiroyuki Kimura, Ryoichi Narita, Koichiro Furuta, Namiki Izumi	1
7	The efficacy and safety of lenvatinib in patients who did not meet the inclusion criteria of the phase 3 trial (REFLECT trial) in real-world practice in Japan: A nationwide multicenter study in Japan. 2019 ·Journal of Clinical Oncology ·Kaoru Tsuchiya, Masayuki Kurosaki, Hiroyuki Marusawa, Takehiko Abe, Chikara Ogawa, Tetsuro Sohda, Hiroyuki Kimura, Masahiko Kondo, Keiji Tsuji, Koichiro Furuta, Masaya Shigeno, Kouji Joko, Ryoichi Narita, Yasushi Uchida, Hideo Yoshida, Takehiro Akahane, Haruhiko Kobashi, Akeri Mitsuda, Yuji Kojima, Namiki Izumi, (unknown)	3
8	A nationwide multicenter study in patients with unresectable hepatocellular carcinoma treated with lenvatinib in real world practice in Japan. 2019 ·Journal of Clinical Oncology ·Kaoru Tsuchiya, Masayuki Kurosaki, Shun Kaneko, Tōru Kimura, Hiroyuki Marusawa, Hirotaka Arai, Takehiko Abe, Hiroyuki Kimura, Keiji Tsuji, Koichiro Furuta, Chikara Ogawa, Ryoichi Narita, Yuji Kojima, Takehiro Akahane, Yasushi Uchida, Hideo Yoshida, Haruhiko Kobashi, Atsunori Kusakabe, Kouji Joko, Namiki Izumi, (unknown)	1
9	Effects of Omeprazole on Sleep Disturbance: Randomized Multicenter Double-Blind Placebo-Controlled Trial 2014 ·Clinical and Translational Gastroenterology ·Masahito Aimi, Yoshinori Komazawa, (unknown), Yuko Yamane, Koichiro Furuta, Yasushi Uchida, Shozo Yano, Miwa Morita, Hiroaki Oguro, Tatsuya Miyake, Toshitsugu Sugimoto, (unknown), Kohji Naora, (unknown), Shunji Ishihara, Yoshikazu Kinoshita	9
10	Prevalence of organic colonic lesions in patients meeting Rome III criteria for diagnosis of IBS: a prospective multi-center study utilizing colonoscopy 2012 ·Journal of Gastroenterology ·Shunji Ishihara, Kazuo Yashima, Yoshinori Kushiyama, Akio Izumi, Kousaku Kawashima, Hirofumi Fujishiro, (unknown), Yoshinori Komazawa, (unknown), Tetsuo Yamamoto, (unknown), Tatsunori Shimizu, (unknown), (unknown), Koichiro Furuta, Naoya Noguchi, Hisao Tanaka, Yoshikazu Murawaki, Yoshikazu Kinoshita	34
11	Does gastroesophageal reflux have an influence on bleeding from esophageal varices? 2008 ·Journal of Gastroenterology ·(unknown), Yuji Amano, (unknown), Koichiro Furuta, Tatsuya Miyake, Shuichi Sato, Shunji Ishihara, Yoshikazu Kinoshita	13
12	Anti-tumor effects of cimetidine on hepatocellular carcinomas in diethylnitrosamine-treated rats 2008 ·Oncology Reports ·Koichiro Furuta, Shuichi Sato, (unknown), (unknown), (unknown), Shunji Ishihara, Yuji Amano, Kyoichi Adachi, Yoshikazu Kinoshita	20
13	S1922 Predictive Factors for Severity of Liver Histology in Patients with Non-Alcoholic Steatohepatitis: Usefulness of Measurement of Arteriosclerosis Indicators 2008 ·Gastroenterology ·Koichiro Furuta, Shuichi Sato, (unknown), (unknown), Hiroshi Tobita, Tatsuya Miyake, Shunji Ishihara, Yuji Amano, Kyoichi Adachi, Riruke Maruyama, Yoshikazu Kinoshita	2
14	Ferucarbotran expands area treated by radiofrequency ablation in rabbit livers 2007 ·Journal of Gastroenterology and Hepatology ·Tatsuya Miyake, Shuichi Sato, (unknown), (unknown), Naoki Oshima, (unknown), Tomoko Mishiro, Koichiro Furuta, Shunji Ishihara, Kyoichi Adachi, Yuji Amano, Yoshikazu Kinoshita	3
15	A Japanese case of eosinophilic esophagitis 2006 ·Journal of Gastroenterology ·Koichiro Furuta, Kyoichi Adachi, (unknown), Yuko Mishima, Hiroshi Imaoka, (unknown), (unknown), Tatsuya Miyake, Yasunori Kadowaki, Kenji Furuta, Hideaki Kazumori, Shuichi Sato, Shunji Ishihara, Yuji Amano, Masaaki Honda, Yoshikazu Kinoshita	54
16	Quantitative measurement of hepatitis B virus DNA in different areas of hepatic lobules in patients with chronic hepatitis B 2005 ·Journal of Medical Virology ·Shunji Mishiro, Sachiko Hamamoto, Koichiro Furuta, Norihisa Ishimura, M. A. Karim Rumi, Tatsuya Miyake, Shuichi Sato, Shunji Ishihara, Kyoichi Adachi, Yoshikazu Kinoshita	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact